Resource Category: Publications

Lorem ipsum dolor sit amet consectetur. Nibh duis augue hendrerit erat lobortis.

Introduction Mi tincidunt elit, id quisque ligula ac diam, amet. Vel etiam suspendisse morbi eleifend faucibus eget vestibulum felis. Dictum quis montes, sit sit. Tellus aliquam enim urna, etiam. Mauris posuere vulputate arcu amet, vitae nisi, tellus tincidunt. At feugiat

促进mRNA疗法:pHLIP可增强脂质纳米颗粒中的内体逃逸和基因表达

Caixia Liu et al. Adv Healthc Mater. 2025.

一项化学生物学筛选研究揭示了神经内分泌癌细胞对SQLE抑制的敏感性

Mahoney CE, Pirman D, Crompton JG, et al. A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition. Nat Commun. 2019;10(1):96.

Exploration of a Class of Aryl Imidazolyl Ureas As Potent Acid Ceramidase Inhibitors for the Treatment of Fibrotic Diseases

Beresis R, et al. ACS Omega. 2025 Jul 31;10(31):34747-34761. doi: 10.1021/acsomega.5c03734. eCollection 2025 Aug 12.

mRNAdesigner: an integrated web server for optimizing mRNA design and protein translation in eukaryotes

Ouyang Mo et al. Nucleic Acids Res. 2025 Jul 7;53(W1):W415-W426. doi: 10.1093/nar/gkaf410.

新型GSPT1降解剂AB138在急性髓系白血病中的抗白血病活性及其作用机制评估

Liqiang Wang, Xin Cai, Yongsheng Wang, Yang Kong, Qingchun Wu, Wei Hu, et al. Invest New Drugs. 2025 Jun;43(3):646-655. doi: 10.1007/s10637-025-01541-8. Epub 2025 May 14.

发现ART0380——一种强效且选择性的ATR激酶抑制剂,目前正处于治疗晚期或转移性实体瘤的II期临床试验阶段

Carroll CL, Li M, Wu Q, et al. J Med Chem. 2024 Dec 26;67(24):21890-21904. doi: 10.1021/acs.jmedchem.4c01595. Epub 2024 Dec 4.

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

Pilié PG, Hung Le et al. Clin Cancer Res. 2024 May 15;30(10):2121-2139. doi: 10.1158/1078-0432.CCR-23-1763.

Identification of tau-tubulin kinase 1 inhibitors by microfluidics-based mobility shift assay from a kinase inhibitor library

Jinlei Wang, et al. SLAS Discov. 2023 Dec;28(8):385-393. doi: 10.1016/j.slasd.2023.06.003. Epub 2023 Jul 1.
开启您的旅程
模态
治疗领域